104 related articles for article (PubMed ID: 12789601)
1. Status of therapies in development for the treatment of age-related macular degeneration.
Hunt DW; Margaron P
IDrugs; 2003 May; 6(5):464-9. PubMed ID: 12789601
[TBL] [Abstract][Full Text] [Related]
2. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
[TBL] [Abstract][Full Text] [Related]
3. Current treatment of age-related macular degeneration.
Zarbin M; Szirth B
Optom Vis Sci; 2007 Jul; 84(7):559-72. PubMed ID: 17632299
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of the wet form of age-related macular disease: the present state and perspectives].
Figurska M; Stankiewicz A
Klin Oczna; 2005; 107(4-6):334-9. PubMed ID: 16118952
[TBL] [Abstract][Full Text] [Related]
5. [Age related macular degeneration: a review of anti-angiogenic treatments].
Razavi S; Coscas G; Soubrane G
J Fr Ophtalmol; 2002 Sep; 25(7):747-52. PubMed ID: 12399735
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic approaches to age-related macular degeneration today.
Bressler NM
Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
[TBL] [Abstract][Full Text] [Related]
8. Wet age-related macular degeneration.
Kulkarni AD; Kuppermann BD
Adv Drug Deliv Rev; 2005 Dec; 57(14):1994-2009. PubMed ID: 16309781
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neovascular age-related macular degeneration: past, present and future directions.
Smith BT; Joseph DP; Grand MG
Curr Opin Ophthalmol; 2007 May; 18(3):240-4. PubMed ID: 17435433
[TBL] [Abstract][Full Text] [Related]
10. [Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration].
Coscas F; Stanescu D; Coscas G; Soubrane G
J Fr Ophtalmol; 2003 Jun; 26(6):602-8. PubMed ID: 12910200
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy for choroidal neovascularization not caused by age related macular degeneration or pathologic myopia].
Torrón Fernández-Blanco C; Pérez Oliván S; Ferrer Novella E; Ruiz-Moreno O; Marcuello Melendo B; Honrubia López FM
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):471-6. PubMed ID: 14517732
[TBL] [Abstract][Full Text] [Related]
12. Age-related macular degeneration: diagnosis and management.
Cook HL; Patel PJ; Tufail A
Br Med Bull; 2008; 85():127-49. PubMed ID: 18334518
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
14. [Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report].
Hassenstein A; Richard G
Klin Monbl Augenheilkd; 2003 Jul; 220(7):492-5. PubMed ID: 12886510
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy versus thermal laser photocoagulation for the treatment of recurrent choroidal neovascularization due to AMD.
Kallitsis A; Moschos MM; Ladas ID
In Vivo; 2007; 21(6):1049-52. PubMed ID: 18210754
[TBL] [Abstract][Full Text] [Related]
16. [Intravitreal anti-VEGF injections improve the visual prognosis of wet age related macular degeneration].
Ambresin A; Mantel I
Rev Med Suisse; 2007 Jan; 3(94):137-41. PubMed ID: 17354539
[TBL] [Abstract][Full Text] [Related]
17. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience].
Wykrota H; Gierek-Lapińska A; Trzciakowski K; Gajdzik-Gajdecka U
Klin Oczna; 2007; 109(10-12):402-9. PubMed ID: 18488382
[TBL] [Abstract][Full Text] [Related]
18. [Frequency of neovascular lesion types in wet age-related macular degeneration].
Gierek-Lapińska A; Wykrota H; Trzciakowski K; Szymkowiak M; Gierek-Ciaciura S
Klin Oczna; 2004; 106(3 Suppl):463-5. PubMed ID: 15636237
[TBL] [Abstract][Full Text] [Related]
19. Age-related macular degeneration.
Brucker AJ
Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
[TBL] [Abstract][Full Text] [Related]
20. Emerging pharmacologic therapies for wet age-related macular degeneration.
Ni Z; Hui P
Ophthalmologica; 2009; 223(6):401-10. PubMed ID: 19622904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
